Alumni working in our Equity Portfolio companies
By linking world-class scientific developments with industry, we take research from the lab to the market, creating real-world economic, environmental and society-wide value.
Many of our alumni now work in companies that originated at CSIRO. Read through the links and stories below to find out more about their work.
And if you’re working within one of these companies – please feel free to get in touch and share your latest news.
Our portfolio companies
Read about over 180 companies that have been born from CSIRO technology. These companies have a combined market capitalisation in excess of AUD$3 billion.
Learn more about our Investment Portfolio team and structure.
Hear from alumni
Nancy Schellhorn : Nancy is one of our CSIRO Alumni members and the CEO and co-founder of RapidAIM
Paul Sims: Paul originally worked on the BARLEYmax® commercialisation when he was at CSIRO and left to join The Healthy Grain
Silvia Pfeiffer: Silvia is the CEO and Co-Founder of CSIRO spin-out and a successful ON alumni Coviu
Portfolio company news
We are keen to support and promote our equity portfolio companies, so please get in touch if you’d like to share your latest news.
You can also check out our news page and search for tagged companies or key words.
July 2023
Futurefeed: Asparagopsis feed additive research answering industry questions
NextOre: RFC Ambrian tips into NextOre Series B capital raise; plans IPO
June 2023
Omnisova: Supporting eggcellence in cooperative research
NutriV: This cauliflower and pumpkin ice cream is a delicious way to get your five a day
May 2023
Amfora: McClintock and Amfora Form Strategic Collaboration to Leverage AI to Improve Protein Content of Soy
Evergen: CSIRO to build Australia-first mobile hydrogen generator
April 2023
RFC Ambrian: CSIRO technology to help global landmine clearing efforts
March 2023
Arista Cereals: New High-Fibre Wheat Enters Australian Market with 6x More Fibre
Quasar Satellite Technologies: Dish disruptor Quasar Satellite Technologies raises $6m in pre-Series A round
January 2023
‘Orange is the new Palo Alto’: Why the next Atlassian, Canva will be from the bush
Saluda Medical: Saluda Medical Announces Presentation of 36-Month Trial Data at NANS 2023 Annual Meeting